DE60204224D1 - Verwendung bestimmter substituierter pyrrolidone wie z.b. piracetam bei der behandlung von viralen und anderen erkrankungen - Google Patents

Verwendung bestimmter substituierter pyrrolidone wie z.b. piracetam bei der behandlung von viralen und anderen erkrankungen

Info

Publication number
DE60204224D1
DE60204224D1 DE60204224T DE60204224T DE60204224D1 DE 60204224 D1 DE60204224 D1 DE 60204224D1 DE 60204224 T DE60204224 T DE 60204224T DE 60204224 T DE60204224 T DE 60204224T DE 60204224 D1 DE60204224 D1 DE 60204224D1
Authority
DE
Germany
Prior art keywords
treatment
diseases
piracetam
virals
certain substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60204224T
Other languages
English (en)
Other versions
DE60204224T2 (de
Inventor
Jacques Peuvot
Robert Brasseur
Michel Deleers
Fausto A Pontes
Jean-Marie Ruysschaert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB SA
Original Assignee
UCB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB SA filed Critical UCB SA
Application granted granted Critical
Publication of DE60204224D1 publication Critical patent/DE60204224D1/de
Publication of DE60204224T2 publication Critical patent/DE60204224T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE60204224T 2001-03-22 2002-03-20 Verwendung bestimmter substituierter pyrrolidone wie z.b. piracetam bei der behandlung von viralen und anderen erkrankungen Expired - Lifetime DE60204224T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01107140 2001-03-22
EP01107140 2001-03-22
PCT/EP2002/003106 WO2002076451A1 (en) 2001-03-22 2002-03-20 Use of certain substituted pyrrolidones such as piracetam in the treatment of viral and other diseases

Publications (2)

Publication Number Publication Date
DE60204224D1 true DE60204224D1 (de) 2005-06-23
DE60204224T2 DE60204224T2 (de) 2006-02-02

Family

ID=8176886

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60204224T Expired - Lifetime DE60204224T2 (de) 2001-03-22 2002-03-20 Verwendung bestimmter substituierter pyrrolidone wie z.b. piracetam bei der behandlung von viralen und anderen erkrankungen

Country Status (6)

Country Link
US (1) US20040092575A1 (de)
EP (1) EP1392290B1 (de)
AT (1) ATE295727T1 (de)
DE (1) DE60204224T2 (de)
ES (1) ES2242024T3 (de)
WO (1) WO2002076451A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7371364B2 (en) 2003-08-15 2008-05-13 Board Of Regents, The University Of Texas System Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy
EP1667967B1 (de) * 2003-09-24 2012-08-01 UCB Pharma, S.A. Verfahren zur herstellung von 2-oxo-1-pyrrolidinderivaten
US7157421B2 (en) 2004-12-27 2007-01-02 Miller Landon C G Piracetam and piracetam analog conjugate and a pharmaceutical composition for treatment of neuronal disorders
US8420602B2 (en) * 2004-09-14 2013-04-16 Landon C. G. Miller Endocannabinoid conjugate and a pharmaceutical composition for treatment of neuronal disorders
NZ554157A (en) * 2005-07-26 2010-12-24 Glaxo Smithkline Trading Services Ltd Pharmaceutical compositions comprising levetiracetam and process for their preparation
US20080014271A1 (en) * 2006-07-13 2008-01-17 Ucb, S.A. Novel pharmaceutical compositions comprising levetiracetam
US9101628B2 (en) * 2007-09-18 2015-08-11 The Board Of Trustees Of The Leland Stanford Junior University Methods and composition of treating a flaviviridae family viral infection
JP5715820B2 (ja) * 2007-09-18 2015-05-13 スタンフォード ユニバーシティー フラビウイルス科ファミリーのウイルスへの感染を治療する方法ならびに、フラビウイルス科ファミリーのウイルスへの感染を治療するための組成物
US9149463B2 (en) * 2007-09-18 2015-10-06 The Board Of Trustees Of The Leland Standford Junior University Methods and compositions of treating a Flaviviridae family viral infection
US8940730B2 (en) 2007-09-18 2015-01-27 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions of treating a Flaviviridae family viral infection
JP2012520884A (ja) 2009-03-18 2012-09-10 ザ ボード オブ トラスティーズ オブ ザ リランド スタンフォード ジュニア ユニバーシティー フラビウイルス科ウイルス感染症を治療する方法および組成物
CN103073477A (zh) * 2013-01-24 2013-05-01 吉林三善恩科技开发有限公司 以3,4-二羟基苯甲酸为前驱体的吡拉西坦药物共晶及其制备方法
CN103044306A (zh) * 2013-01-24 2013-04-17 吉林化工学院 一种新型吡拉西坦药物共晶及其制备方法
DE102021003961A1 (de) 2021-07-29 2023-02-02 CARMFI Holding AG Verfahren zur Herstellung wässriger Arzneimittellösungen mit unterschiedlichen Zusammensetzungen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE864269A (fr) * 1977-03-03 1978-06-16 Parke Davis & Co Nouveaux n-(aminoalkyl substitue)-2-oxo-1-pyrrolidine-acetamides et procedes pour les produire
GB8412358D0 (en) * 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition

Also Published As

Publication number Publication date
WO2002076451A1 (en) 2002-10-03
EP1392290B1 (de) 2005-05-18
ES2242024T3 (es) 2005-11-01
DE60204224T2 (de) 2006-02-02
ATE295727T1 (de) 2005-06-15
US20040092575A1 (en) 2004-05-13
EP1392290A1 (de) 2004-03-03

Similar Documents

Publication Publication Date Title
DE60204224D1 (de) Verwendung bestimmter substituierter pyrrolidone wie z.b. piracetam bei der behandlung von viralen und anderen erkrankungen
HUS1700003I1 (hu) Pirimidinamin-származékok és ezeket tartalmazó gyógyászati készítmények, mint angiogenézis modulátorok
DE69435096D1 (de) Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
ATE386538T1 (de) Kombinierte verwendung von faktor vii polypeptiden und faktor viii polypeptiden
ATE508635T1 (de) Virusvektoren und ihre verwendung bei therapeutischen methoden
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
EP1408986A4 (de) Proteomimetische verbindungen und verfahren
MXPA02006679A (es) Composicion farmaceutica.
ATE526019T1 (de) Verfahren zur behandlung von zellproliferationen störungen und virusinfektionen
DE69838986D1 (de) Polypeptide, deren herstellung und verwendung
DE60137307D1 (de) Substituierte sapogenine und ihre verwendung
DE60126321D1 (de) Gelsystem zur ocularen verabreichung von arzneimitteln
ATE273031T1 (de) Aminobiguanide und ihre verwendung zur desinfektion von kontaktlinsen und konservierung von pharmazeutischen zubereitungen
DE69716469D1 (de) Pharmazeutische zusammensetzung enthaltend ein osteogenese foerderndes mittel und ein polyethylen-glycol
CA2531419C (fr) Procede de stabilisation d'un cryoprecipite de proteines plasmatiques destine a etre soumis a un traitement thermique d'inactivation virale
ATE213233T1 (de) Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit
WO2001043693A3 (en) Polynucleotide vaccines expressing codon optimized hiv-1 nef and modified hiv-1 nef
ATE310828T1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
DK1418905T3 (da) Terapeutisk middel til depletering af en uönsket proteinpopulation fra plasma
DE60229924D1 (de) Fusionsproteine zur spezifisichen behandlung von krebs und autoimmunkrankheiten
TR199901385T2 (xx) Piperidin t�revleri.
UA9703A (uk) Антипротеіназний засіб
AU2002302447A1 (en) Use of certain substituted pyrrolidones such as piracetam in the treatment of viral and other diseases
TR200000916T2 (tr) İkameli piperidin türevleri.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition